Cosentyx (secukinumab) is a safe and effective treatment for ankylosing spondylitis (AS), producing similar results in Chinese patients…
Articles by Marisa Wexler MS
AbbVie has submitted an application to the U.S. Food and Drug Administration (FDA) requesting the approval of…
An under-the-skin injectable formulation of Remsima (infliximab), called Remsima SC, has been approved in European Union for the…
On days when they are more mindful or engaged in meaningful activities, people with ankylosing spondylitis or rheumatoid…
Eli Lilly‘s Taltz (ixekizumab) has been approved in the U.S. to treat non-radiographic axial spondyloarthritis (nr-axSpA) in…
Both treatment with Humira (adalimumab) and smoking can alter the composition of the gut microbiome — the microorganisms living…
Elevated levels of a protein produced in both bones and the gut, known as lipocalin 2 (LCN2), could explain…
Use of tumor necrosis factor alpha (TNF) inhibitors is linked to a higher risk of inflammatory disorders affecting the nervous…
The Committee for Medicinal Products for Human Use (CHMP) is recommending the approval of Cosentyx (secukinumab) for…
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Nepexto, a biosimilar of Enbrel…